|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
Labbok M, K Cooney and S Coly. 1994. Guidelines for Breastfeeding and the Lactational Amenorrhea Method. Institute for Reproductive Health: Washington, D.C. Lettenmaier C and ME Gallen. 1987. Why counseling counts! Population Reports Series J(36): 1–28. Population Action International. 1991. A Guide to Methods of Birth Control (wall chart). Population Action International: Washington, D.C. Trussell J et al. 1990. A guide to interpreting contraeptive efficacy studies. Obstetrics and Gynceology 76:558–567. World Health Organization. 1993. Facts about once-a-month injectable contraceptives: Memorandum from a WHO meeting. Bulletin of the World Health Organization 71(6): 677–689.
Fraser IS. 1992. Vaginal bleeding patterns with monthly injectable contraceptives. Contraception 49(4): 399–420. Sastrawinata S et al. 1991. A comparative clinical trial of the TCu 380A, Lippes Loop D and Multiload Cu 375 IUDs in Indonesia. Contraception 44(2): 141–154. Technical Guidance Working Group. November 1994. Recommendations for Updating Selected Practices in Contraceptive Use, Vol. 1. Program for International Training in Health: Chapel Hill, North Carolina. Walling M. 1992. A multicenter efficacy and safety study of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol. Contraception 46(4): 313–326. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
Postabortion Consortium. 1995. Postabortion Care. JHPIEGO Corporation: Baltimore, Maryland. Yordy L, S Johnson and J Winkler. 1993. MVA Trainer's Handbook. IPAS: Carrboro, North Carolina.
Ellertson C. 1994. Research in emergency contraception. South to South Newsletter 4:1–4, 12. Ellertson C et al. 1995. Expanding access to emergency contraception in developing countries. Studies in Family Planning 26(5): 251–263. Glasier A et al. 1992. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. New England Journal of Medicine 327(15): 1041–1044. Haspels AA. 1994. Emergency contraception: A review. Contraception 50(2): 101–108. Postabortion Consortium. 1995. Postabortion Care. JHPIEGO Corporation: Baltimore, Maryland. Service Delivery Issues in Emergency Contraception. 1996. International Medical Advisory Panel Meeting of the International Planned Parenthood Federation. London, England, February 20, 1996. Trussell J et al. 1992. Emergency contraceptive pills: a simple proposal to reduce unintended pregnancies. Family Planning Perspectives 24(6): 269–73. World Health Organization (WHO). 1992. Progress in Human Reproduction, No. 21. WHO: Geneva.
Hatcher RA et al. 1994. Contraceptive Technology, 16th ed. Irvington Publishers, Inc: New York. Labbok M, K Cooney and S Coly. 1994. Guidelines for Breastfeeding and the Lactational Amenorrhea Method. Institute for Reproductive Health: Washington, D.C.
Family Health International (FHI). How to Take the Pill. FDA Patient Package Insert Instructions for OC Use. FHI: Research Triangle Park, North Carolina. Goldzieher JW and NM Zamah. 1995. Oral contraceptive side effects: Where's the beef? Contraception 52: 327–335. Newer OCs and Blood Clot Risks. 1996. Network. 16(2) :28–29. Rizack MA and CDM Hillman. 1985. The Medical Letter Handbook of Adverse Drug Interactions. The Medical Letter: New Rochelle, New York. Technical Guidance Working Group. November 1994. Recommendations for Updating Selected Practices in Contraceptive Use, Vol. 1. Program for International Training in Health: Chapel Hill, North Carolina. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
McIntosh N et al (eds). 1993. IUD Guidelines for Family Planning Service Programs, 2nd ed. JHPIEGO Corporation: Baltimore, Maryland. Technical Guidance Working Group. November 1994. Recommendations for Updating Selected Practices in Contraceptive Use, Vol. 1. Program for International Training in Health: Chapel Hill, North Carolina. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
McCann MF and LS Potter. 1994. Progestin-only oral contraception: A comprehensive review. Contraception 50(6 Supp 1): s1–s195. McIntosh N et al (eds). 1995. Norplant® Implants Guidelines for Family Planning Service Programs, 2nd ed. JHPIEGO Corporation: Baltimore, Maryland. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use. World Health Organization (WHO). 1990. Injectable Contraceptives: Their Role in Family Planning Care. WHO: Geneva.
Pardthaisong T and R Gray. 1991. In utero exposure to steroid contraceptives and outcome of pregnancy. American Journal of Epidemiology 134(8): 795–803. Pardthaisong T, C Yenchit and R Gray. 1992. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. Contraception 45(4): 313–324. Stone R. 1992. Depo-Provera: controversial contraceptive wins approval from FDA panel. Science 256(5065): 1754. World Health Organization (WHO). 1991. Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. International Journal of Cancer 49(2): 182–185. World Health Organization (WHO). 1992. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception 45(4): 299–312. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
Population Action International. 1991. A Guide to Methods of Birth Control (wall chart). Population Action International: Washington, D.C. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
Population Action International. 1991. A Guide to Methods of Birth Control (wall chart). Population Action International: Washington, D.C. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
Population Action International. 1991. A Guide to Methods of Birth Control (wall chart). Population Action International: Washington, D.C. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
Population Action International. 1991. A Guide to Methods of Birth Control (wall chart). Population Action International: Washington, D.C. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
Peterson HB et al. 1996. The risk of pregnancy after tubal sterilization: Findings from the US Collaborative Review of Sterilization. American Journal of Obstetrics and Gynecology 174: 1161–1170. World Federation of Health Agencies for the Advancement of Voluntary Surgical Contraception. 1988. Safe and Voluntary Surgical Contraception. AVSC: New York. World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
World Health Organization. 1996. Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use.
Larson EL. 1988. Guideline for use of topical antimicrobial agents. American Journal of Infection Control 16(6): 253–266. Larson EL et al. 1990. Alcohol for surgical scrubbing? Infection Control and Hospital Epidemiology 11(3): 139–143. Pereira LJ et al. 1990. The effect of surgical handwashing routines on the microbial counts of operating room nurses. American Journal of Infection Control 18(6): 354–364. Program for International Training in Health (INTRAH). 1992. Guidelines for Clinical Procedures in Family Planning. A Reference for Trainers, 2nd ed. INTRAH: Chapel Hill, North Carolina. Rotter M et al. 1980. Povidone-iodine and chlorhexidine gluconate-containing detergents for disinfection of hands. Journal of Hospital Infection 1: 149–158. Spaulding EH. 1968. Chemical disinfection of medical and surgical materials in Disinfection, Sterilization, and Preservation. Lawrence CA et al (eds). Lea & Febiger: Philadelphia, Pennsylvania. Tietjen L et al. (Forthcoming.) Infection Prevention for Family Planning Service Programs, 2nd ed. JHPIEGO Corporation: Baltimore, Maryland. Wenzel RP (ed). 1993. Prevention and Control of Nosocomial Infections. Williams & Wilkins: Baltimore, Maryland.
Lande R. 1993. Controlling sexually transmitted diseases. Population Reports Series L(9). JHPIEGO. 1991. Genital Tract Infection Guidelines for Family Planning Service Programs. JHPIEGO Corporation: Baltimore, Maryland. World Health Organization (WHO). 1994. Management of Sexually Transmitted Diseases. WHO: Geneva.
|
![[TOC]](../../6images/PG/blrtoc.gif){kind=small}
![[Top]](../../6images/PG/blrtop.gif){kind=small}